Molecular complex for targeting antigens towards cells comprising antigens and uses thereof for vaccination

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10385120
APP PUB NO 20130195908A1
SERIAL NO

13576083

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a molecular complex for targeting the antigen towards cells comprising antigens, including at least one antigen associated with at least two ligands of surface molecules of cells comprising antigens, said complex including at least one first ligand of a sulphated sugar of the glycosaminoglycan family and a second ligand of a specific surface molecule of cells comprising antigens, and said first ligand being covalently bonded with said antigen and/or said second ligand.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
COMMISSARIAT A L'ENERGIE ATOMIQUE31-33 RUE DE LA FEDERATION PARIS 15-EME 75752

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boulain, Jean-Claude Palaiseau, FR 6 52
Gadzinski, Adeline Villeparisis, FR 4 35
Leonetti, Michel Nozay, FR 6 36
Savatier, Alexandra Etampes, FR 4 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 20, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 20, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00